Ten pupils burn to death in Tanzania school fire
Ten pupils have died in a fire in a school dormitory in north-western Tanzania's Kagera region.
Seven other pupils who sustained serious injuries have been...
Nigerian state approves castration of child rapists
The state assembly in Kaduna, in north-western Nigeria, has approved full surgical castration as punishment for those convicted of raping children under 14.
State commissioner...
Zambia to reopen schools and bars
Zambia’s President Edgar Lungu has announced the reopening of schools and bars as Covid-19 cases begin to slow.
Addressing parliament in Lusaka on Friday, Mr...
US Wildfires: Mahama chides US Gov’t for abdicating fight against climate change
Former President John Dramani Mahama has berated the US government for shooting itself in the foot following the latter's disinterest in the fight against...
Guinea’s top court clears Alpha Condé third term bid
Guinea's constitutional court, the highest in the West African country, has approved 82-year-old President Alpha Condé's bid for a third term in next month's...
Ivory Coast party threatens to boycott elections
Ivory Coast's party, the Democratic Party of Cote d'Ivoire - African Democratic Rally, has threatened to boycott October's general elections if conditions to make...
Liberia’s Charles Taylor ‘bid to move prison rejected’
A special court in Sierra Leone has rejected a bid by convicted former Liberian President Charles Taylor to be moved from a British prison...
Buhari condemns third-term bids by West African leaders
Nigeria's President Muhammadu Buhari has called on West African leaders to stick to their constitutional term limits.
The comments follow decisions by Ivory Coast's President...
China ‘eyes four African nations for military bases’
China is considering setting up military bases in four African countries, according to a report by the US Department of Defense.
Kenya, Seychelles, Tanzania and...
Russia vaccine ‘passes early trial test’
Patients involved in early tests of a Russian coronavirus vaccine developed antibodies with "no serious adverse events", according to research published in The Lancet...